FAINARDI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 9.013
EU - Europa 2.534
AS - Asia 1.660
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
AF - Africa 7
SA - Sud America 2
Totale 13.237
Nazione #
US - Stati Uniti d'America 9.008
CN - Cina 961
UA - Ucraina 578
IT - Italia 532
DE - Germania 365
TR - Turchia 358
GB - Regno Unito 314
PL - Polonia 249
SG - Singapore 233
SE - Svezia 157
FI - Finlandia 147
FR - Francia 47
BE - Belgio 42
CZ - Repubblica Ceca 31
HK - Hong Kong 30
ID - Indonesia 26
AT - Austria 25
VN - Vietnam 17
IR - Iran 16
A2 - ???statistics.table.value.countryCode.A2??? 7
AU - Australia 7
RU - Federazione Russa 7
EU - Europa 6
NL - Olanda 6
RO - Romania 6
IN - India 5
KR - Corea 5
CA - Canada 4
IE - Irlanda 4
MA - Marocco 4
PT - Portogallo 4
CH - Svizzera 3
ES - Italia 3
IQ - Iraq 3
SI - Slovenia 3
BR - Brasile 2
HR - Croazia 2
HU - Ungheria 2
JP - Giappone 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 13.237
Città #
Woodbridge 1.338
Fairfield 1.093
Chandler 767
Houston 716
Jacksonville 673
Ashburn 606
Ann Arbor 561
Wilmington 394
Seattle 371
Cambridge 360
Warsaw 239
Izmir 234
Nanjing 218
Ferrara 184
Princeton 180
Beijing 159
Singapore 145
Milan 136
Boardman 122
New York 116
Shanghai 106
San Diego 90
Addison 81
Dearborn 80
Nanchang 66
Shenyang 62
Bremen 59
Jiaxing 50
Hebei 46
Tianjin 43
Brussels 42
Changsha 41
Norwalk 38
Falls Church 32
Los Angeles 31
Hong Kong 30
Brno 29
San Mateo 28
Jakarta 26
Ningbo 25
Vienna 25
Jinan 23
Orange 23
Redwood City 23
Auburn Hills 21
Mountain View 18
Zhengzhou 18
Kunming 17
Bologna 16
Guangzhou 16
London 16
Dong Ket 15
Tappahannock 15
Des Moines 13
Hefei 13
Rome 13
Taizhou 13
Verona 13
Washington 13
Leawood 12
Ardabil 10
Helsinki 9
Kraków 9
Indiana 8
Philadelphia 8
Augusta 7
Hangzhou 7
Kilburn 7
Munich 6
Redmond 6
Changchun 5
Lanzhou 5
San Francisco 5
Burnley 4
Clifton 4
Haikou 4
Monmouth Junction 4
Parma 4
Simi Valley 4
Calderara Di Reno 3
Catania 3
Dublin 3
Ferrara di Monte Baldo 3
Forest City 3
Fuzhou 3
Greifensee 3
Guardialfiera 3
Hounslow 3
Modena 3
Padova 3
Reggio Emilia 3
Sant'elena 3
Shaoxing 3
Acton 2
Amsterdam 2
Andover 2
Chicago 2
Chiswick 2
Dolo 2
Győr 2
Totale 10.125
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 340
HLA-G Molecules in Autoimmune Diseases and Infections 157
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 150
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 147
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 140
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 133
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 132
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 131
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 130
Emerging topics and new perspectives on HLA-G 130
Cerebrospinal fluid analysis and the determination of oligoclonal bands 124
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 123
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 123
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 122
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 122
null 121
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 121
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 121
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 120
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 120
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 118
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 116
Survival prediction in high-grade gliomas using CT perfusion imaging 115
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 114
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 114
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 113
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 113
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 112
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 111
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 111
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 111
Leptin/adiponectin ratio predicts post-stroke neurological outcome 111
null 110
null 109
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 107
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 106
null 104
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 104
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 104
null 102
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 102
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 101
New insights into HLA-G and inflammatory diseases 99
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 98
null 97
null 97
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 97
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 97
null 96
Some basic aspects of HLA-G biology. 96
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 96
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 94
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 93
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 93
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 92
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 91
Neurofilament ELISA validation 90
null 90
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 89
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 88
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 88
null 88
null 87
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 87
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 86
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 86
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 86
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 85
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 85
null 84
null 84
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 84
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 84
null 83
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 82
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 82
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 81
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 81
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 80
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 80
Le catene leggere libere liquorale sclerosi multipla 79
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 76
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 76
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 75
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 75
null 75
Detection of Parachlamydialike organisms in patients with multiple sclerosis. 74
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 73
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 71
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 71
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 70
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 69
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 69
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 68
null 68
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 67
Under the microscope: Focusing on Chlamydia pneumoniae infection and Multiple Sclerosis 66
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci. 66
null 66
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 66
Totale 10.011
Categoria #
all - tutte 58.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 483
Totale 59.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.812 485 112 112 386 172 345 260 282 207 296 102 53
2020/20211.843 153 131 72 195 78 178 64 221 70 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/2025102 102 0 0 0 0 0 0 0 0 0 0 0
Totale 13.522